Highly Selective Syngas/H2 Production via Partial Oxidation of CH4 Using (Ni, Co and Ni–Co)/ZrO2–Al2O3 Catalysts: Influence of Calcination Temperature

In this study, Ni, Co and Ni–Co catalysts supported on binary oxide ZrO2–Al2O3 were synthesized by sol-gel method and characterized by means of various analytical techniques such as XRD, BET, TPR, TPD, TGA, SEM, and TEM. This catalytic system was then tested for syngas respective H2 production via partial oxidation of methane at 700 °C and 800 °C. The influence of calcination temperatures was studied and their impact on catalytic activity and stability was evaluated. It was observed that increasing the calcination temperature from 550 °C to 800 °C and addition of ZrO2 to Al2O3 enhances Ni metal-support interaction. This increases the catalytic activity and sintering resistance. Furthermore, ZrO2 provides higher oxygen storage capacity and stronger Lewis basicity which contributed to coke suppression, eventually leading to a more stable catalyst. It was also observed that, contrary to bimetallic catalysts, monometallic catalysts exhibit higher activity with higher calcination temperature. At the same time, Co and Ni–Co-based catalysts exhibit higher activity than Ni-based catalysts which was not expected. The Co-based catalyst calcined at 800 °C demonstrated excellent stability over 24 h on stream. In general, all catalysts demonstrated high CH4 conversion and exceptionally high selectivity to H2 (~98%) at 700 °C

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication

The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019

Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe

Male fertility and its association with occupational and mobile phone towers hazards: An analytic study

Objective: The aim of the study is to determine the association of male fertility with the occupational and mobile phone towers hazards. Background: Male reproductive ability is likely to have multiple genetic and environmental determinants. A seminal fluid analysis is clinical marker of male reproductive potential. Aim: To find out whether environmental hazard such as mobile phone tower has an effect on male reproductive ability. Methods: Two hundred couples were enrolled, one hundred subfertile couples as a study group (n = 100), and one hundred fertile couples as a control group (n = 100). Environmental exposure to electromagnetic radiation from mobile phone towers and occupational state was assessed by standard questionnaire. Semen analysis was done for the subfertile males, because the fertile males (control group) refused to give semen samples. Results: The occupational hazard expressed significant difference between the subfertile and the control groups (38% versus 12%) (p < 0.05), with odds ratio (OR) = 4.5 and 95% Confidence Interval (CI): 2.175–9.288, and also the environmental factor (mobile tower within fifty meters from their house) showed significant difference (29% versus 12%) (p < 0.05), with OR = 3; 95% CI: 1.426–6.290. SFA of the subfertile males was 40% abnormal versus 60% normal semen analysis. These abnormalities were classified into 35% oligozoospermia, 55% asthenospermia, and 10% teratozoospermia. Oligozoospermia was associated with more occupational hazard (OR = 1.8, 95% CI: 0.569–5.527). Teratozoospermia was associated with more occupational hazard (OR = 5.23, 95% CI: 0.524–52.204), and with exposure to environmental hazard (OR = 2.6, 95% CI: 0.342–19.070), and associated with smoking hazard (OR = 1.7, 95% CI: 0.225–12.353). Conclusions: Male fertility represented by quality of semen might be affected by occupational and environmental exposures, so it seems that prevention of occupational and environmental risk factors, may lead to improvement of semen quality in subfertile men

Assessment of anti-Mullerian hormone level in reproductive age group women with diabetes mellitus type one

Objective: To assess the levels of anti-Mullerian hormone in women with type I diabetes mellitus during their reproductive age period. Background: Reproductive impairment in poorly controlled type one diabetes mellitus results from perturbations at different levels of the gonadotropic axis, including the hypothalamus/pituitary and the ovary. Methods: This study was designed as a case-control study. We evaluated anti-Mullerian hormone serum level in a female with type I diabetes mellitus (N = 60) who attended the Diabetes and Endocrine Center in Merjan Medical city in Babylon, from November 2015 to April 2016. These patients were compared with a healthy fertile female (N = 80) as a control group. The female's age ranges from 13 to 40 years for the two groups. Body mass index was calculated and serum samples for anti-Mullerian hormone serum levels were estimated. Results: There was a significant difference between patients and control group regarding body mass index, residence, educational level, fertility, and menarche. Anti-Mullerian hormone level is significantly lower in patient group when compared with the control group (p = 0.000∗). HbA1c level is significantly higher in a patient group when compared with the control group (p = 0.000∗). Conclusion: The results suggest that type I diabetes is an independent risk factor for decrease of anti-Mullerian hormone level in reproductive age group women

Highly nanocrystalline Mg doped ZnFe2O4 powders for rapid and simultaneous adsorption of lead, copper, and cadmium heavy metals ions in synthetic/sea waters

This research aims to investigate the effect of Mg doping on individual and simultaneous adsorption of Pb+2, Cu+2, and Cd+2 heavy metals in aqueous solution and in seawater samples, by Zinc ferrite nanoparticles. The Mg-doped Zinc ferrite nanoparticles are synthesized successfully by the sol-gel route and varying Mg concentrations. TEM, XRD, FTIR, Raman, and XPS characterizations confirm the cubic spinel structure of Zinc ferrite with a semi-spherical shaped nanosized particles (10–15 nm) irrespective of Mg doping content. The BET surface area manifests a significant increase within Mg doping (39.3 m2/g) compared with the pure zinc ferrite (28.4 m2/g). Accordingly, Mg-doped Zinc ferrite powders demonstrate considerable adsorption capacities for Pb+2 (143.5 mg/g), Cu+2 (117 mg/g), and Cd+2 (77 mg/g) within 2 h under optimized experimental conditions. The prepared nanopowders exhibit high selectivity towards Pb+2 in simultaneous adsorption in aqueous solutions (85 mg/g) and real seawater samples. Nonetheless, the selectivity of Pb+2 ions drops dramatically to 25 mg/g within real seawater samples due to the strong ionic strength of high-salinity seawater. This study provides insights into the importance of doped spinel ferrite nanoparticles in highly efficient, rapid, and simultaneous adsorption of heavy metals. Besides, it reveals the challenge of performing the adsorption process in real seawater

Highly Selective Syngas/H2 Production via Partial Oxidation of CH4 Using (Ni, Co and Ni–Co)/ZrO2–Al2O3 Catalysts: Influence of Calcination Temperature

In this study, Ni, Co and Ni&ndash;Co catalysts supported on binary oxide ZrO2&ndash;Al2O3 were synthesized by sol-gel method and characterized by means of various analytical techniques such as XRD, BET, TPR, TPD, TGA, SEM, and TEM. This catalytic system was then tested for syngas respective H2 production via partial oxidation of methane at 700 &deg;C and 800 &deg;C. The influence of calcination temperatures was studied and their impact on catalytic activity and stability was evaluated. It was observed that increasing the calcination temperature from 550 &deg;C to 800 &deg;C and addition of ZrO2 to Al2O3 enhances Ni metal-support interaction. This increases the catalytic activity and sintering resistance. Furthermore, ZrO2 provides higher oxygen storage capacity and stronger Lewis basicity which contributed to coke suppression, eventually leading to a more stable catalyst. It was also observed that, contrary to bimetallic catalysts, monometallic catalysts exhibit higher activity with higher calcination temperature. At the same time, Co and Ni&ndash;Co-based catalysts exhibit higher activity than Ni-based catalysts which was not expected. The Co-based catalyst calcined at 800 &deg;C demonstrated excellent stability over 24 h on stream. In general, all catalysts demonstrated high CH4 conversion and exceptionally high selectivity to H2 (~98%) at 700 &deg;C

A validation study comparing the sensitivity and specificity of the new Dr. KSU H1N1 RT-PCR kit with real-time RT-PCR for diagnosing influenza A (H1N1)

<b>Background and Objectives:</b> A new test (Dr. KSU H1N1 RT-PCR kit) was recently developed to provide a less expensive alternative to real-time reverse transcriptase-polymerase chain reaction (RT-PCR). We report the findings of a validation study designed to assess the diagnostic accuracy, including sensitivity and specificity, of the new kit, as compared to real-time RT-PCR. <b>Design and Setting:</b> Cross-sectional validation study conducted from 18-22 November 2009 at a primary care clinic for H1N1 at a tertiary care teaching hospital in Riyadh. <b>Patients and Methods:</b> Nasopharyngeal swab samples and data on socio-demographic characteristics and symptoms were collected from 186 patients. Swab samples were sent to the laboratory for testing with both real-time RT-PCR and the new Dr. KSU H1N1 RT-PCR kit. We measured the sensitivity and specificity of the new test across the entire sample size and investigated how these values were affected by patient socio-demographic characteristics and symptoms. <b>Results</b>: The outcomes of the two tests were highly correlated (kappa=0.85; <i>P</i>&lt;.0001). The sensitivity and specificity of the new test were 99.11&#x0025; and 83.78&#x0025;, respectively. The sensitivity of the new test was affected only minimally (96&#x0025;-100&#x0025;) by patient characteristics and number of symptoms. On the other hand, the specificity of the new test varied depending on how soon patients were tested after onset of symptoms (100&#x0025; specificity when swabs were taken on the first day of the symptoms, decreasing to 75&#x0025; when swabs were taken on or after the third day). The specificity of the new test also increased with increasing body temperature. <b>Conclusion:</b> The new test seems to provide a cost-effective alternative to real-time RT-PCR for diagnosing H1N1 influenza. However, further testing may be needed to verify the efficacy of the test in different settings and communities